本文關(guān)鍵詞：一期前路病灶清除植骨內(nèi)固定術(shù)治療頸椎間隙感染的臨床研究　出處：《新疆醫(yī)科大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 頸椎 椎間隙感染 植骨 內(nèi)固定器

【摘要】：目的:探討一期前路病灶清除植骨內(nèi)固定術(shù)治療頸椎間隙感染的臨床療效。方法:回顧性分析2010年6月至2014年6月我院行一期前路病灶清除植骨合內(nèi)固定術(shù)治療且獲得完整隨訪的68例頸椎間隙感染患者的資料,男42例,女26例;年齡17~79歲,平均53.6歲。單間隙感染56例(C_(2/3) 3例,C_(3/4) 9例,C_(4/5) 15例,C_(5/6) 24例,C6/7 3例)、相鄰雙間隙感染12例(C_(2/3)和C_(3/4) 3例,C_(3/4)和C_(4/5) 2例,C_(4/5)和C_(5/6)7例)。術(shù)后依據(jù)診斷給予抗炎治療,監(jiān)測紅細胞沉降率(erythrocyte sedimentation rate,ERS)及C-反應(yīng)蛋白(C-reactive protein,CRP)評估感染控制情況。采用Eck融合和分級標(biāo)準(zhǔn)[10]評價植骨融合情況,臨床療效評價采用視覺模擬評分(visual analogue scale,VAS)、日本骨科協(xié)會(Japanese Orthopaedic Association Scores,JOA)評分(頸椎)。結(jié)果:68例患者均順利完成手術(shù),手術(shù)時間60-90min,平均70min;術(shù)中出血量30-150ml,平均88ml,診斷化膿性頸椎間隙感染14例,結(jié)核性頸椎間隙感染39例,布氏桿菌頸椎間隙感染8例,不明原因頸椎間隙感染7例。術(shù)后隨訪時間13~32個月,平均15.7個月。術(shù)后患者臨床癥狀均明顯緩解。頸部VAS評分術(shù)前平均5.3±2.7分,術(shù)后1月為2.3±2.5分,術(shù)后6月為0.9±1.6,末次隨訪為1.0±1.3分,術(shù)后頸部VAS評分較術(shù)前明顯降低,差異有統(tǒng)計學(xué)意義(P0.05)。術(shù)前JOA評分平均10.8±3.5分,術(shù)后1月為13.4±4.7分,術(shù)后6月為15.6±3.6分,末次隨訪為15.9±2.5分;JOA改善率為78.4%。所有患者在隨訪期無內(nèi)固定松動現(xiàn)象。術(shù)后有7例患者出現(xiàn)聲嘶,給與甲鈷胺片口服,隨訪觀察一月后痊愈。2例患者術(shù)后2周內(nèi)出現(xiàn)切口感染,經(jīng)再次清創(chuàng)后痊愈。結(jié)論:一期前路病灶清除植骨內(nèi)固定術(shù)治療頸椎間隙感染可徹底清除病灶、解除神經(jīng)壓迫并提供堅強內(nèi)固定,術(shù)后病理診斷及細菌培養(yǎng)可提供針對性的抗炎治療,療效確切,是一種良好的治療方法。
[Abstract]:Objective: to investigate the clinical effect of one stage anterior debridement and bone grafting internal fixation in the treatment of cervical space infection. The data of 68 patients with cervical space infection who were treated with anterior debridement and bone grafting and internal fixation from June 2010 to June 2014 were analyzed retrospectively. 42 males and 26 females; The average age was 53.6 years, with 56 cases of single space infection (n = 56) and 3 cases with C / C / 3 / 4) 9 cases with C / C / 4 / 5 (n = 15). There were 24 cases of C6 / 7 / 7, 12 cases of contiguous double gap infection, and 3 cases of C / S / 3 / 4) and 3 cases of C / S 3 / 4) and 2 cases of C / S 4 / 5). Che 4 / 5) and Che 5 / 6 / 6 cases were treated with anti-inflammatory therapy according to the diagnosis after operation. Erythrocyte sedimentation rate and erythrocyte sedimentation rate were monitored. ERS) and C-reactive protein (CRP) were used to evaluate infection control. Eck fusion and grading criteria were used. [10] to evaluate the fusion of bone graft, visual analogue scale scale was used to evaluate the clinical efficacy. Japanese Orthopaedic Association Scores. Results all 68 patients were successfully operated, the operation time was 60-90 mins (mean 70 mins); The intraoperative bleeding volume was 30-150 ml (mean 88 ml). 14 cases were diagnosed as suppurative cervical space infection, 39 cases as tuberculous cervical space infection and 8 cases as brucellosis infection. The follow-up time was 13 ~ 32 months (mean 15.7 months). The clinical symptoms of the patients were obviously relieved. The average score of cervical VAS score was 5.3 鹵2.7 before operation. The scores of postoperative VAS were 2.3 鹵2.5 on January, 0.9 鹵1.6 on June, and 1.0 鹵1.3 on the last follow-up. The cervical VAS score was significantly lower than that before operation. The average JOA score was 10.8 鹵3.5,13.4 鹵4.7 in January and 15.6 鹵3.6 in June. The last follow-up was 15.9 鹵2.5 minutes. The improvement rate of JOA was 78.4%. There was no internal fixation loosening in all patients during the follow-up period. After operation, 7 patients developed hoarseness and were given mecoamin tablets orally. All patients were followed up for 2 weeks after January. The wound infection occurred in 2 weeks after operation and was cured after re-debridement. Conclusion: one stage anterior debridement and bone grafting and internal fixation can completely clear the focus of cervical intervertebral space infection. Relieving nerve compression and providing strong internal fixation, postoperative pathological diagnosis and bacterial culture can provide targeted anti-inflammatory treatment. It is a good treatment method.
【學(xué)位授予單位】：新疆醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R687.3

【參考文獻】

相關(guān)期刊論文 前7條

1 王葵光，，胡有谷;腰椎間盤突出癥的自身免疫狀態(tài)[J];中華骨科雜志;1994年05期

2 周勁松,陳建庭,金大地,劉金標(biāo);結(jié)核分枝桿菌對材料粘附能力的體外實驗研究[J];中國脊柱脊髓雜志;2003年11期

3 郭立新,陳興,馬遠征,宋金寶,史操英;TFC植入術(shù)后脊椎間盤炎及外科策略[J];骨與關(guān)節(jié)損傷雜志;2002年01期

4 馬遠征,胡明,才曉軍,陳興,李宏偉,隰建成,薛海濱;脊柱結(jié)核外科治療的探討[J];中華骨科雜志;2005年02期

5 高曉磊;吳清民;;人類布氏桿菌病[J];中國獸醫(yī)雜志;2011年12期

6 尚暉;皮海菊;王達義;;一期前路病灶清除植骨內(nèi)固定術(shù)治療頸椎化膿性感染[J];骨科;2016年02期

7 陳華江;王建喜;滕紅林;曹鵬;肖建如;倪斌;袁文;;一期病灶清除術(shù)治療頸椎結(jié)核[J];中華骨科雜志;2014年02期

本文編號：1423869